The clinic research of of inhalational sevoflurane anesthesia induction on endotracheal intubation in pediatric patients with congenital heart disease

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16007818

Enrollment

Unknown

Registered

2016-01-23

Start date

2016-01-23

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

two groups:sevoflurane

Eligibility

Sex/Gender

All

Age

4 Years to 12 Years

Inclusion criteria

Inclusion criteria: Forty ASA physical status I/II pediatric patients, aged 4-12 years, scheduled for interventricular septal defect repair or interatrial septal defect repair, were randomly divided into two groups (n=20 each): intravenous induction group and inhalational sevoflurane anesthesia induction group.

Exclusion criteria

Exclusion criteria: Excluding Severe pulmonary hypertension Right to left shunt heartandSevere acute respiratory diseases.

Design outcomes

Primary

Measure	Time frame
Endothelin;	—

Countries

China

Contacts

Public ContactWei Shao

492991401@qq.com+86 0535 6602199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026